Awedio.sg is now part of the SPH Media website.

Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term

The issuer is solely responsible for the content of this announcement.

Published by SPH Media Limited, Co. Regn. No. 202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.